Deborah S. Mortensen

Synthesis and Biological Evaluation of a Novel Series of Furans:  Ligands Selective for Estrogen Receptor α

Deborah S. Mortensen, Alice L. Rodriguez, Kathryn E. Carlson et al. · Journal of Medicinal Chemistry · 2001 · 246 citations

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +15

Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens

Brian E. Fink, Deborah S. Mortensen, Shaun R. Stauffer et al. · Chemistry & Biology · 1999 · 223 citations · Full text

Estrogen-receptor Ligands, Combinatorial Chemistry, Medicinal Chemistry +9

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma

Johanna C. Bendell, Robin Kate Kelley, Kent C. Shih et al. · Cancer · 2015 · 75 citations · Full text

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115

Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin et al. · Journal of Medicinal Chemistry · 2015 · 72 citations · Full text

Drug Target, Kinase Inhibitors, Pharmacotherapy +16

Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes

Usha Ghosh, Deshanie Ganessunker, Viswajanani J. Sattigeri et al. · Bioorganic & Medicinal Chemistry · 2003 · 67 citations

Heterocyclic, Estrogenic Diazenes, Medicine +8